Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Probo Medical Acquires Mi Healthcare
Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair, and service, […]
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the […]
Amgen to Acquire Chemocentryx for $4 Billion in Cash
Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to […]
Gilead Sciences to Acquire MiroBio
Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company focused on restoring […]
Advanced Instruments Acquires SAL Scientific, Expertise, and a Range of Cell Growth Supplements in Support of Research & Drug Discovery Workflows
Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the […]
Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis
Mymee, a leading provider of specialized care and support for people with significant symptoms associated […]
Velocity Clinical Research Begins European Expansion With German Site Acquisition
Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, today announces it has acquired […]
Valo Therapeutics Acquires PeptiCHIP Technology Enabling Rapid Identification of Tumor Antigens for the Development of Personalized Immunotherapies
Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious […]
Somalogic Acquires DNA Nanotechnology Leader Palamedrix to Develop the Next-generation SomaScan® Assay
SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into […]
Ginkgo to Acquire Zymergen
Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more